Article info

PDF
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates

Authors

  1. Correspondence to Dr Susana Sánchez-Fidalgo, Department of Pharmacology, University Hospital Valme, Avenida de Bellavist, Seville 41012, Spain; fidalgo{at}us.es
View Full Text

Citation

Fobelo Lozano MJ, Sánchez-Fidalgo S
Adherence and preference of intravenous zoledronic acid for osteoporosis versus other bisphosphonates

Publication history

  • Received March 7, 2017
  • Revised July 13, 2017
  • Accepted August 1, 2017
  • First published September 20, 2017.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.